If you dissect the contemporary mainstream media coverage of Amazon (or any big-tech), you'd realise it's mostly paid promotion (and limit the extent of reporting on "anti-trust" action). Amazon usually stands out for its predatory pricing - by outbidding or sustaining losses in a vertical and then driving out the competitors. Let's look at the … Continue reading On Amazon’s cancer vaccine →